Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA
AN12855 is a novel cofactor-independent inhibitor of Mycobacterium tuberculosis InhA. AN12855 has potent activity against M. tuberculosis , good oral bioavailability, and comparable efficacy to isoniazid in infection models. New antitubercular agents are needed to combat the spread of multidrug- and...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Life Science Alliance LLC
2018-06-01
|
| Col·lecció: | Life Science Alliance |
| Accés en línia: | https://www.life-science-alliance.org/lookup/doi/10.26508/lsa.201800025 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
